International archives of occupational and environmental health · 2026
Effects of DCBA exposure on liver fibrosis and NAFLD: a comprehensive investigation integrating NHANES data analysis, network toxicology, and molecular docking.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fu Yansong, Wang Jiayun, Zeng Xin, Qin Hong
Аннотация
PURPOSE: This study examined associations between urinary 3-diethyl-carbamoyl benzoic acid (DCBA), the principal metabolite of the insect repellent DEET, and liver fibrosis (LF) as well as non-alcoholic fatty liver disease (NAFLD) using a nationally representative sample. Network toxicology approaches were employed to explore underlying molecular mechanisms.
METHODS: We analyzed 5,960 adults from NHANES with DCBA measurements obtained through liquid chromatography-tandem mass spectrometry. LF severity was determined using NAFLD Fibrosis Score (NFS ≥ 0.676), whereas NAFLD was identified via sex-specific alanine aminotransferase criteria. Weighted logistic regression models incorporated progressive adjustment for demographic, anthropometric, and clinical factors. Network toxicology identified molecular targets, with molecular docking and dynamics simulations validating mechanistic pathways.
RESULTS: DCBA exposure showed significant positive correlations with LF risk after full adjustment (OR = 1.254, 95% CI: 1.097-1.432, P < 0.001), demonstrating clear dose-response patterns (P-trend = 0.019). However, DCBA exhibited no meaningful relationship with NAFLD prevalence (OR = 1.002, 95% CI: 0.935-1.074, P = 0.954). Alcohol intake substantially modified the DCBA-LF relationship (interaction P = 0.002), showing stronger effects in drinkers (OR = 1.45, 95% CI: 1.23-1.69). Epidermal growth factor receptor emerged as the key molecular target with strongest binding capacity ( -6.9 kcal/mol).
CONCLUSION: DCBA displays selective correlations with hepatic fibrosis independent of steatotic processes, with alcohol potentiating fibrogenic effects. These results establish new exposure-response relationships for common environmental chemicals and advance mechanistic understanding for risk assessment applications.
METHODS: We analyzed 5,960 adults from NHANES with DCBA measurements obtained through liquid chromatography-tandem mass spectrometry. LF severity was determined using NAFLD Fibrosis Score (NFS ≥ 0.676), whereas NAFLD was identified via sex-specific alanine aminotransferase criteria. Weighted logistic regression models incorporated progressive adjustment for demographic, anthropometric, and clinical factors. Network toxicology identified molecular targets, with molecular docking and dynamics simulations validating mechanistic pathways.
RESULTS: DCBA exposure showed significant positive correlations with LF risk after full adjustment (OR = 1.254, 95% CI: 1.097-1.432, P < 0.001), demonstrating clear dose-response patterns (P-trend = 0.019). However, DCBA exhibited no meaningful relationship with NAFLD prevalence (OR = 1.002, 95% CI: 0.935-1.074, P = 0.954). Alcohol intake substantially modified the DCBA-LF relationship (interaction P = 0.002), showing stronger effects in drinkers (OR = 1.45, 95% CI: 1.23-1.69). Epidermal growth factor receptor emerged as the key molecular target with strongest binding capacity ( -6.9 kcal/mol).
CONCLUSION: DCBA displays selective correlations with hepatic fibrosis independent of steatotic processes, with alcohol potentiating fibrogenic effects. These results establish new exposure-response relationships for common environmental chemicals and advance mechanistic understanding for risk assessment applications.